For the quarter ending 2026-03-31, MNOV made $186,984 in revenue. -$2,587,208 in net income. Net profit margin of -1383.65%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | 186,984 | 151,739 | 123,319 | 134,599 |
| Costs of services | 170,101 | 146,985 | 115,272 | 116,349 |
| Research, development and patents | 1,262,514 | 1,543,419 | 1,582,975 | 2,188,652 |
| General and administrative | 1,590,175 | 1,553,737 | 1,806,070 | 1,436,690 |
| Total operating expenses | 3,022,790 | 3,244,141 | 3,504,317 | 3,741,691 |
| Operating loss | -2,835,806 | -3,092,402 | -3,380,998 | -3,607,092 |
| Interest income | 252,964 | 301,876 | 340,850 | 324,955 |
| Other income (expense), net | -3,416 | -5,759 | -10,225 | 952 |
| Loss before income taxes | - | -2,800,780.5* | - | - |
| Income tax expense | - | 1,498.5* | - | - |
| Net loss | -2,586,258 | -2,802,279 | -3,050,373 | -3,281,185 |
| Foreign currency translation adjustments | -950 | -377 | 568 | 2,681 |
| Comprehensive loss | -2,587,208 | -2,802,656 | -3,049,805 | -3,278,504 |
| Basic EPS | -0.05 | -0.057 | -0.06 | -0.07 |
| Diluted EPS | -0.05 | -0.057 | -0.06 | -0.07 |
| Basic Average Shares | 49,221,246 | 49,115,014 | 49,046,246 | 49,046,246 |
| Diluted Average Shares | 49,221,246 | 49,115,014 | 49,046,246 | 49,046,246 |
MEDICINOVA INC (MNOV)
MEDICINOVA INC (MNOV)